Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Elacestrant is indicated for the treatment of postmenopausal women or adult men ···【more】
Release date：2026-02-02Recommended：155
Anagrelide is indicated to reduce the risk of blood clots in patients with throm···【more】
Release date：2026-01-30Recommended：115
Special caution is required when using anagrelide, as certain drugs may interact···【more】
Release date：2026-01-30Recommended：102
Anagrelide may cause a range of side effects during use.What side effects may An···【more】
Release date：2026-01-30Recommended：112
Anagrelide is used to reduce the platelet count in patients with myeloproliferat···【more】
Release date：2026-01-30Recommended：108
Revumenib (Revuforj) is an oral, first-in-class targeted Menin protein inhibitor···【more】
Release date：2026-01-29Recommended：163
Revumenib (trade name: Revuforj) is an oral, first-in-class targeted Menin inhib···【more】
Release date：2026-01-29Recommended：147
Revumenib (trade name: Revuforj) is an oral targeted drug of the Menin inhibitor···【more】
Release date：2026-01-29Recommended：175
Revuforj carries a risk of differentiation syndrome, and patients and their fami···【more】
Release date：2026-01-29Recommended：163
Rivimeinib is available in three tablet strengths: 25 mg, 110 mg, and 160 mg.Wha···【more】
Release date：2026-01-28Recommended：136
Combination of this class of drugs with Revuforj is not recommended; if co-admin···【more】
Release date：2026-01-28Recommended：149
Remission is the primary treatment goal for acute myeloid leukemia (AML) and acu···【more】
Release date：2026-01-28Recommended：178
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
